HC Surgical Specialists Limited (SGX: 1B1)

Market Cap	40.76M
Revenue (ttm)	19.05M
Net Income (ttm)	3.85M
Shares Out	153.81M
EPS (ttm)	0.03
PE Ratio	10.49
Forward PE	n/a
Dividend	0.01 (5.28%)
Ex-Dividend Date	Nov 8, 2024

Volume	33,200
Open	0.260
Previous Close	0.260
Day's Range	0.260 - 0.265
52-Week Range	0.240 - 0.420
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 4, 2024

About HC Surgical Specialists

HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other g...

• Industry: Offices and Clinics of Doctors of Medicine
• Founded: 2015
• Country: Singapore
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 1B1

Financial Performance

In 2024, HC Surgical Specialists's revenue was 20.21 million, an increase of 4.13% compared to the previous year's 19.41 million. Earnings were 3.85 million, an increase of 31.76%.